Invizius Limited Revenue and Competitors

Motherwell,

Location

N/A

Total Funding

Estimated Revenue & Valuation

  • Invizius Limited's estimated annual revenue is currently $5.5M per year.(i)
  • Invizius Limited's estimated revenue per employee is $251,000

Employee Data

  • Invizius Limited has 22 Employees.(i)
  • Invizius Limited grew their employee count by 47% last year.

Invizius Limited's People

NameTitleEmail/Phone
1
CEOReveal Email/Phone
2
CFOReveal Email/Phone
3
Chief Operating Officer: Complement Modulating Therapeutics preventing Fibrosis and Inflammation.Reveal Email/Phone
4
Co-Founder and Chief Technology OfficerReveal Email/Phone
5
Quality ManagerReveal Email/Phone
6
Finance ManagerReveal Email/Phone
7
Research ScientistReveal Email/Phone
8
Financial ControllerReveal Email/Phone
9
Principal ScientistReveal Email/Phone
10
Principal ScientistReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$5M40-18%$10MN/A
#2
$24.8M9929%N/AN/A
#3
$84.1M0N/A$1.2MN/A
#4
$35.6M14230%N/AN/A
#5
$57.5M2296%N/AN/A
#6
$52.7M16825%$129.6MN/A
#7
$21.1M84-3%N/AN/A
#8
$61.2M244-13%N/AN/A
#9
$60.6M19320%$115.5MN/A
#10
$56.2M179-3%$122.9MN/A
Add Company

What Is Invizius Limited?

Invizius is a spin-out based on world-class research carried out at the University of Edinburgh, Scotland, developing solutions to improve the treatment and prognosis for dialysis patients. Despite significant improvements in the quality and efficacy of hemodialysis therapy in recent years, cardiovascular disease (CVD) remains the leading cause of death for dialysis patients. Today, almost half of all dialysis patients die from cardiovascular complications. With its proprietary H-Guardâ„¢ technology, Invizius is addressing the side effects of hemodialysis to help patients feel better, and suffer fewer cardiovascular complications.

keywords:N/A

N/A

Total Funding

22

Number of Employees

$5.5M

Revenue (est)

47%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Invizius Limited News

2022-03-30 - Invizius Awarded Major Biomedical Catalyst Grant to bring ...

Invizius Limited is a late pre-clinical-stage biotechnology company developing treatments to suppress unwanted innate immune responses, focused...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$32.4M128-6%N/A
#2
$20.5M1288%N/A
#3
$38M1411%N/A
#4
$56.1M2084%N/A
#5
$35M7014%N/A